Related Experiment Video
Updated: Jan 18, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Diabetic wound healing via a co-delivery system for bone marrow derived stem cells and euphorbia hirta extract: an in
Jiazhang Duan1, Yun Yao1, Jiafei Wang1
1Department of Hand and Foot Surgery, The Affiliated Hospital of Yunnan University, Kunming City, China.
Abstract:
Diabetes mellitus, a persistent metabolic disorder characterized by elevated blood glucose levels, presents a substantial global health challenge due to its escalating prevalence and associated complications. In the current study, a nanofibrous scaffold was developed for the co-delivery of bone marrow-derived stem cells and Euphorbia hirta extract into the diabetic wound beds. Scaffolds were produced using the electrospinning method, and their physicochemical and biological properties were studied in vitro. The wound healing function of the developed delivery system was investigated in a rat model of diabetic wound healing. The study showed that Euphorbia hirta extract-loaded scaffolds imparted no significant toxicity toward L929 cells and promoted their migration activity. A wound healing study showed that scaffolds loaded with both bone marrow-derived stem cells and euphorbia hirta extract had the highest wound healing activity, as shown by significantly higher wound closure percentage, collagen deposition, and epithelial thickness. Enzyme-linked immunosorbent Assay studies showed that these dressings reduced tissue oxidative stress and alleviated inflammatory responses.

